Area of research
Dermatology · Oncology
Research interest
Research interests include Cutaneous Melanoma Detection and Management, Cutaneous lymphoproliferative disorders research, Autoimmune Bullous Skin Diseases, and Drug-Induced Adverse Reactions.
Discordance, accuracy and reproducibility study of pathologists’ diagnosis of melanoma and melanocytic tumors
Efficacy and safety of biologics for hidradenitis suppurativa: A network meta‐analysis of phase III trials
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)
Benign or Malignant? Ex Vivo Confocal Laser Scanning Microscopy for Bedside Histological Assessment of Melanocytic Lesions
Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors
Association of HLA-A*02:01 type with efficacy and toxicity of immune checkpoint inhibitor therapy in melanoma patients: a retrospective cohort study
LL37 complexed to double-stranded RNA induces RIG-I-like receptor signalling and Gasdermin E activation facilitating IL-36γ release from keratinocytes
59674 Randomized Phase 3 trial of spesolimab in patients with ulcerative pyoderma gangrenosum: A study protocol
Spatial proteomics identifies JAKi as treatment for a lethal skin disease
Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics
Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors
Recent progress in Stevens–Johnson syndrome/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment
Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and management
Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient care
Checkpoint inhibitor–induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression level
Checkpoint inhibitor‐induced bullous pemphigoid differs from spontaneous bullous pemphigoid
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens‐Johnson syndrome and toxic epidermal necrolysis) – Part 1: Diagnosis, initial management, and immunomodulating systemic therapy
Unveiling the hidden boundaries: AI‐assisted line‐field optical coherence tomography margin mapping for precise excision of basal cell carcinoma – A step‐by‐step tutorial
Targeting IL-1 controls refractory pityriasis rubra pilaris
Optimized monitoring for immune checkpoint inhibitor induced myocarditis using high-sensitivity troponin-T
Extracorporeal Photopheresis as a Treatment Option for Immune-Related Adverse Events: Two Case Reports and a Prospective Study
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens‐Johnson syndrome and toxic epidermal necrolysis) – Part 2: Supportive therapy of EN in the acute and post‐acute stages
Medical algorithm: Diagnosis and treatment of drug reaction with eosinophilia and systemic symptoms in adult patients
Exploring the potential of omega‐3 fatty acids in acne patients: A prospective intervention study
Patients’ and dermatologists’ preferences in artificial intelligence–driven skin cancer diagnostics: A prospective multicentric survey study
Skin Cancer Induction by the Antimycotic Drug Voriconazole Is Caused by Impaired DNA Damage Detection Due to Chromatin Compaction
Using multiple real-world dermoscopic photographs of one lesion improves melanoma classification via deep learning
Characteristics of Gut Microbiota in Rosacea Patients—A Cross-Sectional, Controlled Pilot Study